Evidence map›Paper›PMID 40086852›Full record

ArticleBMJ case reports2025

Postmenopausal endometriosis.

Kemala Isnainiasih Mantilidewi, Steven Ridwan, Andi Kurniadi, Ali Budi Harsono

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kemala Isnainiasih MantilidewiObstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.ORCID http://orcid.org/0000-0003-4588-8018
Steven RidwanObstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.ORCID http://orcid.org/0000-0001-8714-774X
Andi KurniadiObstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.ORCID http://orcid.org/0000-0003-0731-3512
Ali Budi HarsonoObstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia ali.budi@unpad.ac.id.ORCID http://orcid.org/0000-0001-6342-321X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A postmenopausal woman, in her 60s, married with no history of pregnancy, presented to our facility with an abdominal mass of 2 months duration that progressively increased in size. Physical examination revealed a mobile abdominal cystic mass measuring approximately 20×20×10 cm, accompanied by ascites. Transvaginal ultrasonography showed a hypoechoic cystic mass measured >14.6×12.5 x13.5×11.49 cm, with septa and papillary projections, and the Doppler colour score was +2, along with ascites. Based on the IOTA Simple Rules, this mass would be classified as malignant, because it meets the criteria for M2 (ascites) and M4 (irregular multilocular solid tumour ≥100 mm) features. Because malignancy was suspected, a total hysterectomy and bilateral salpingo-oophorectomy with a frozen section were performed. The frozen section and histopathological examination resulted in a right endometrioma. Postmenopausal endometriosis is rare, but clinicians should always be aware of its existence as it confers a risk of malignant transformation and recurrence. Comprehensive follow-up after surgery is recommended in such cases.

Indexed as

EndometriosisPostmenopauseDiagnosis, DifferentialFemaleHumansHysterectomyMiddle AgedSalpingo-oophorectomyGynaecological cancerMenopause (including HRT)

Identifiers

PMID40086852
PMCPMC11911504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.